Nuvalent Inc-a
(NUVL)
|
12.3 |
$595M |
|
20M |
29.78 |
Glaukos Corp Note 2.750% 6/1 (Principal)
|
6.5 |
$313M |
|
272M |
1.15 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
4.0 |
$191M |
|
242M |
0.79 |
Neurocrine Biosciences
(NBIX)
|
3.7 |
$181M |
|
1.5M |
119.44 |
Sarepta Therapeutics DBCV 1.500%11/1
|
3.4 |
$165M |
|
89M |
1.87 |
Adapthealth Corp Common Stock
(AHCO)
|
3.0 |
$147M |
|
7.6M |
19.22 |
Ionis Pharmaceuticals Note 4/0 (Principal)
|
2.4 |
$118M |
|
128M |
0.93 |
Tabula Rasa Healthcare Note 1.750% 2/1 (Principal)
|
2.4 |
$115M |
|
145M |
0.79 |
Brookdale Sr Living Note 2.000%10/1 (Principal)
|
2.3 |
$112M |
|
146M |
0.77 |
Viatris
(VTRS)
|
2.3 |
$111M |
|
10M |
11.13 |
Catalyst Pharmaceutical Partners
(CPRX)
|
2.3 |
$110M |
|
5.9M |
18.60 |
Natera Note 2.250% 5/0 (Principal)
|
2.2 |
$108M |
|
85M |
1.27 |
Amylyx Pharmaceuticals
(AMLX)
|
2.1 |
$100M |
|
2.7M |
36.95 |
Insmed Note 1.750% 1/1 (Principal)
|
2.0 |
$96M |
|
103M |
0.93 |
Intercept Pharmaceuticals In Note 3.500% 2/1 (Principal)
|
2.0 |
$95M |
|
98M |
0.97 |
Nuvasive Note 1.000% 6/0 (Principal)
|
2.0 |
$95M |
|
97M |
0.98 |
Amedisys
(AMED)
|
2.0 |
$95M |
|
1.1M |
83.54 |
Silverback Therapeutics
(SPRY)
|
2.0 |
$95M |
|
11M |
8.53 |
Apellis Pharmaceuticals Note 3.500% 9/1 (Principal)
|
1.6 |
$79M |
|
52M |
1.53 |
Oak Str Health Note 3/1 (Principal)
|
1.6 |
$76M |
|
100M |
0.76 |
Silk Road Medical Inc Common
(SILK)
|
1.5 |
$74M |
|
1.4M |
52.85 |
Pacira Biosciences Note 0.750% 8/0 (Principal)
|
1.5 |
$74M |
|
82M |
0.90 |
Iveric Bio
|
1.5 |
$73M |
|
3.4M |
21.41 |
Accolade Note 0.500% 4/0 (Principal)
|
1.5 |
$73M |
|
105M |
0.70 |
Larimar Therapeutics
(LRMR)
|
1.4 |
$70M |
|
17M |
4.13 |
Caremax Com Cl A
|
1.2 |
$58M |
|
16M |
3.65 |
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
1.2 |
$57M |
|
70M |
0.81 |
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
1.2 |
$56M |
|
58M |
0.98 |
Guardant Health Note 11/1 (Principal)
|
1.2 |
$56M |
|
89M |
0.63 |
Centene Corporation
(CNC)
|
1.0 |
$46M |
|
565k |
82.01 |
Hillevax
(HLVX)
|
0.9 |
$45M |
|
2.7M |
16.73 |
Phreesia
(PHR)
|
0.9 |
$44M |
|
1.4M |
32.36 |
Livongo Health Note 0.875% 6/0 (Principal)
|
0.9 |
$44M |
|
50M |
0.88 |
Alphatec Hldgs Note 0.750% 8/0 (Principal)
|
0.9 |
$44M |
|
48M |
0.91 |
Mirum Pharmaceuticals
(MIRM)
|
0.8 |
$40M |
|
2.0M |
19.50 |
Enhabit Ord
(EHAB)
|
0.8 |
$39M |
|
3.0M |
13.16 |
1life Healthcare Note 3.000% 6/1 (Principal)
|
0.8 |
$39M |
|
41M |
0.96 |
Deciphera Pharmaceuticals
(DCPH)
|
0.8 |
$39M |
|
2.3M |
16.39 |
Merus N V
(MRUS)
|
0.8 |
$37M |
|
2.4M |
15.47 |
Anaptysbio Inc Common
(ANAB)
|
0.7 |
$36M |
|
1.2M |
30.99 |
Edgewise Therapeutics
(EWTX)
|
0.7 |
$35M |
|
3.9M |
8.94 |
Brookdale Senior Living
(BKD)
|
0.7 |
$35M |
|
13M |
2.73 |
Cogent Biosciences
(COGT)
|
0.7 |
$34M |
|
3.0M |
11.56 |
Vaxcyte
(PCVX)
|
0.7 |
$34M |
|
700k |
47.95 |
Ideaya Biosciences
(IDYA)
|
0.7 |
$32M |
|
1.7M |
18.17 |
ImmunoGen
|
0.7 |
$32M |
|
6.4M |
4.96 |
Ptc Therapeutics Note 1.500% 9/1 (Principal)
|
0.6 |
$31M |
|
32M |
0.98 |
Kura Oncology
(KURA)
|
0.6 |
$30M |
|
2.4M |
12.41 |
Bellus Health Com New
|
0.6 |
$29M |
|
3.6M |
8.22 |
Terns Pharmaceuticals
(TERN)
|
0.6 |
$29M |
|
2.9M |
10.18 |
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.6 |
$27M |
|
2.5M |
10.90 |
Springworks Therapeutics
(SWTX)
|
0.6 |
$27M |
|
1.0M |
26.01 |
Health Catalyst Note 2.500% 4/1 (Principal)
|
0.5 |
$26M |
|
30M |
0.87 |
Vigil Neuroscience
(VIGL)
|
0.5 |
$26M |
|
2.1M |
12.50 |
Evolus
(EOLS)
|
0.5 |
$25M |
|
3.3M |
7.51 |
Owens & Minor
(OMI)
|
0.5 |
$23M |
|
1.2M |
19.53 |
Rain Therapeutics
|
0.5 |
$22M |
|
2.8M |
8.00 |
Denali Therapeutics
(DNLI)
|
0.5 |
$22M |
|
800k |
27.81 |
Revolution Medicines
(RVMD)
|
0.4 |
$21M |
|
892k |
23.82 |
Day One Biopharmaceuticals I
(DAWN)
|
0.4 |
$21M |
|
964k |
21.52 |
Tarsus Pharmaceuticals
(TARS)
|
0.4 |
$19M |
|
1.3M |
14.66 |
Apollo Endosurgery
|
0.4 |
$17M |
|
1.8M |
9.97 |
Xeris Biopharma Holdings Note 5.000% 7/1 (Principal)
|
0.4 |
$17M |
|
18M |
0.95 |
Prime Medicine
(PRME)
|
0.3 |
$16M |
|
885k |
18.58 |
Da32 Life Scnce Tec Acqstn C Class A Com
|
0.3 |
$16M |
|
1.6M |
9.99 |
Krystal Biotech
(KRYS)
|
0.3 |
$14M |
|
175k |
79.22 |
Insmed Com Par $.01
(INSM)
|
0.3 |
$13M |
|
664k |
19.98 |
Singular Genomics Systems In
(OMIC)
|
0.3 |
$13M |
|
6.5M |
2.01 |
Alphatec Hldgs Com New
(ATEC)
|
0.3 |
$13M |
|
1.0M |
12.35 |
Pacira Pharmaceuticals
(PCRX)
|
0.2 |
$11M |
|
292k |
38.61 |
Nuvation Bio Com Cl A
(NUVB)
|
0.2 |
$11M |
|
5.9M |
1.92 |
Kezar Life Sciences
(KZR)
|
0.2 |
$10M |
|
1.4M |
7.04 |
Alector
(ALEC)
|
0.2 |
$9.7M |
|
1.1M |
9.23 |
Castle Biosciences
(CSTL)
|
0.1 |
$6.4M |
|
272k |
23.54 |
Oncology Institu
(TOI)
|
0.1 |
$5.5M |
|
3.4M |
1.65 |
Neogenomics Note 1.250% 5/0 (Principal)
|
0.1 |
$5.5M |
|
6.5M |
0.84 |
Foghorn Therapeutics
(FHTX)
|
0.1 |
$5.0M |
|
778k |
6.38 |
Cabaletta Bio
(CABA)
|
0.1 |
$4.3M |
|
464k |
9.25 |
Acutus Medical
(AFIB)
|
0.1 |
$3.0M |
|
2.7M |
1.15 |
Annexon
(ANNX)
|
0.1 |
$3.0M |
|
584k |
5.17 |
Abeona Therapeutics Com New
(ABEO)
|
0.1 |
$2.7M |
|
870k |
3.08 |
Sema4 Holdings Corp Com Cl A
|
0.1 |
$2.7M |
|
10M |
0.26 |
Graybug Vision Common
|
0.1 |
$2.6M |
|
5.3M |
0.50 |
Nyxoah S A SHS
(NYXH)
|
0.0 |
$2.3M |
|
455k |
4.99 |
Roivant Sciences *w Exp 09/30/202
|
0.0 |
$1.9M |
|
1.0M |
1.94 |
Orchard Therapeutics Spon Ads
|
0.0 |
$1.2M |
|
3.2M |
0.37 |
Pepgen
(PEPG)
|
0.0 |
$802k |
|
60k |
13.37 |
Oncorus
|
0.0 |
$642k |
|
2.5M |
0.25 |
Sientra
|
0.0 |
$544k |
|
2.7M |
0.20 |
Caremax *w Exp 06/08/202
(CMAXW)
|
0.0 |
$351k |
|
672k |
0.52 |
Medavail Holdings Ord
|
0.0 |
$251k |
|
837k |
0.30 |
Butterfly Network *w Exp 02/12/202
(BFLY.WS)
|
0.0 |
$191k |
|
733k |
0.26 |
The Oncology Institute *w Exp 11/15/202
(TOIIW)
|
0.0 |
$138k |
|
1.3M |
0.11 |
Quantum Si *w Exp 06/10/202
(QSIAW)
|
0.0 |
$83k |
|
333k |
0.25 |
Newamsterdam Pharma Company *w Exp 11/22/202
(NAMSW)
|
0.0 |
$81k |
|
93k |
0.87 |
Peak Bio *w Exp 10/26/202
(PKBOW)
|
0.0 |
$73k |
|
363k |
0.20 |
Somalogic *w Exp 08/31/202
|
0.0 |
$48k |
|
120k |
0.40 |
Senior Connect Acquisitn Cor *w Exp 12/31/202
|
0.0 |
$30k |
|
500k |
0.06 |
Medtech Acquisition Corp *w Exp 12/22/202
|
0.0 |
$25k |
|
333k |
0.07 |
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.0 |
$24k |
|
167k |
0.14 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$19k |
|
333k |
0.06 |
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$9.2k |
|
167k |
0.06 |
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.0 |
$10.000000 |
|
1.00 |
10.00 |
Medtech Acquisition Corp Unit 12/18/2025
|
0.0 |
$10.000000 |
|
1.00 |
10.00 |